|
Name |
1,2-Octadecanediol
|
Molecular Formula | C18H38O2 | |
IUPAC Name* |
octadecane-1,2-diol
|
|
SMILES |
CCCCCCCCCCCCCCCCC(CO)O
|
|
InChI |
InChI=1S/C18H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18(20)17-19/h18-20H,2-17H2,1H3
|
|
InChIKey |
XWAMHGPDZOVVND-UHFFFAOYSA-N
|
|
Synonyms |
1,2-Octadecanediol; Octadecane-1,2-diol; Stearyl glycol; 1,2-Dihydroxyoctadecane; 20294-76-2; 9J9GD77RJI; NSC-71534; O-Hexadecylethanediol; UNII-9J9GD77RJI; octadecylene glycol; EINECS 243-711-3; NSC 71534; AI3-14194; NCIOpen2_003464; SCHEMBL439709; STEARYL GLYCOL [INCI]; CHEBI:84956; DTXSID101021743; NSC71534; FT-0605124; Q27158218
|
|
CAS | 20294-76-2 | |
PubChem CID | 89314 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 286.5 | ALogp: | 7.2 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 40.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.368 |
Caco-2 Permeability: | -4.79 | MDCK Permeability: | 0.00002340 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.292 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.306 |
30% Bioavailability (F30%): | 0.942 |
Blood-Brain-Barrier Penetration (BBB): | 0.061 | Plasma Protein Binding (PPB): | 97.70% |
Volume Distribution (VD): | 1.101 | Fu: | 1.60% |
CYP1A2-inhibitor: | 0.336 | CYP1A2-substrate: | 0.193 |
CYP2C19-inhibitor: | 0.276 | CYP2C19-substrate: | 0.056 |
CYP2C9-inhibitor: | 0.144 | CYP2C9-substrate: | 0.939 |
CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.063 |
CYP3A4-inhibitor: | 0.164 | CYP3A4-substrate: | 0.041 |
Clearance (CL): | 6.169 | Half-life (T1/2): | 0.242 |
hERG Blockers: | 0.194 | Human Hepatotoxicity (H-HT): | 0.013 |
Drug-inuced Liver Injury (DILI): | 0.025 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.937 | Carcinogencity: | 0.034 |
Eye Corrosion: | 0.447 | Eye Irritation: | 0.968 |
Respiratory Toxicity: | 0.457 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000082 | 0.767 | D07ILQ | 0.625 | ||||
ENC000486 | 0.758 | D00AOJ | 0.610 | ||||
ENC000789 | 0.758 | D0Z5SM | 0.521 | ||||
ENC000666 | 0.746 | D00FGR | 0.517 | ||||
ENC000488 | 0.734 | D0O1PH | 0.482 | ||||
ENC000284 | 0.723 | D05ATI | 0.444 | ||||
ENC000484 | 0.718 | D0P1RL | 0.391 | ||||
ENC000426 | 0.717 | D00STJ | 0.390 | ||||
ENC000515 | 0.714 | D0T9TJ | 0.372 | ||||
ENC000380 | 0.710 | D0XN8C | 0.318 |